Blueprint Medicines Corp
BPMCDelisted Jul 18, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001597264
Blueprint Medicines Corp was delisted on Jul 18, 2025; its insiders filed their last Form 4 on Jul 21, 2025; 356 institutions reported holding it in 13F filings for Q2 2025, worth $8.65B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Blueprint Medicines Corp as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 215
- −5 vs. Q4 2022
- Shares held
- 63.2M
- +668.7K (+1.1%) vs. Q4 2022
- Total value
- $2.84B
- +$107.4M (+3.9%) vs. Q4 2022
- New holders
- 28
- 91 more added
- Sold out
- 33
- 61 more reduced
3 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BPMC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 4 | $129 |
| Q1 2026 | 6 | $38.6K |
| Q4 2025 | 8 | $2.57M |
| Q3 2025 | 12 | $2.58M |
| Q2 2025 | 356 | $8.65B |
| Q1 2025 | 353 | $6.12B |
| Q4 2024 | 346 | $5.86B |
| Q3 2024 | 319 | $6.04B |
| Q2 2024 | 305 | $7.15B |
| Q1 2024 | 282 | $6.25B |
| Q4 2023 | 260 | $5.91B |
| Q3 2023 | 220 | $3.25B |
| Q2 2023 | 222 | $4.03B |
| Q1 2023 | 215 | $2.84B |
| Q4 2022 | 223 | $2.74B |
| Q3 2022 | 240 | $4.15B |
| Q2 2022 | 237 | $3.19B |
| Q1 2022 | 248 | $3.82B |
| Q4 2021 | 280 | $6.32B |
| Q3 2021 | 289 | $6.13B |
| Q2 2021 | 281 | $5.14B |
| Q1 2021 | 264 | $5.69B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Blueprint Medicines Corp; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Truvestments Capital LLC | 35 | $1.57K | 0.00% | −16−31.4% | Reduced |
| Quent Capital, LLC | 30 | $1.35K | 0.00% | 00.0% | Unchanged |
| First Horizon Advisors, Inc. | 26 | $1.17K | 0.00% | −14−35.0% | Reduced |
| Bell Investment Advisors, Inc | 11 | $495 | 0.00% | +11 | New |
| Parallel Advisors, LLC | 9 | $405 | 0.00% | +9 | New |
| SRS Capital Advisors, Inc. | 7 | $315 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 6 | $270 | 0.00% | +3+100.0% | Added |
| Institutional & Family Asset Management, LLC | 5 | $225 | 0.00% | 00.0% | Unchanged |
| Glassman Wealth Services | 5 | $225 | 0.00% | +5 | New |
| GWM Advisors LLC | 4 | $180 | 0.00% | 00.0% | Unchanged |
| Quadrant Capital Group LLC | 3 | $135 | 0.00% | −27−90.0% | Reduced |
| Proequities, Inc. | 3 | $134 | 0.00% | +3 | New |
| Ellevest, Inc. | 2 | $90 | 0.00% | +2 | New |
| Covestor Ltd | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Transamerica Financial Advisors, Inc. | 1 | – | – | −40−97.6% | Reduced |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −529,456−100.0% | Sold out |
| Westfield Capital Management Co LP | 0 | $0 | 0.00% | −479,467−100.0% | Sold out |
| Nextech Invest AG | 0 | $0 | 0.00% | −188,228−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −130,366−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −85,400−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −40,955−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −39,525−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −31,597−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −26,404−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −21,522−100.0% | Sold out |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −18,168−100.0% | Sold out |
| Moody Aldrich Partners LLC | 0 | $0 | 0.00% | −17,489−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −14,628−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −9,628−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −8,820−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −7,505−100.0% | Sold out |
| Summit Wealth & Retirement Planning, Inc. | 0 | $0 | 0.00% | −5,987−100.0% | Sold out |
| First Republic Investment Management, Inc. | 0 | $0 | 0.00% | −4,831−100.0% | Sold out |
| ETF Managers Group, LLC | 0 | $0 | 0.00% | −4,616−100.0% | Sold out |
| Shell Asset Management Co | 0 | $0 | 0.00% | −4,448−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −4,040−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −1,312−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −1,094−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −941−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −277−100.0% | Sold out |
| Oliver Lagore Vanvalin Investment Group | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Zions Bancorporation, N.A. | 0 | $0 | 0.00% | −58−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| Ci Investments Inc. | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Comerica Bank | – | – | – | – | Not filed |
| HealthCor Management, L.P. | – | – | – | – | Not filed |
| Neo Ivy Capital Management | – | – | – | – | Not filed |